Clinical significance of CD151 overexpression in subtypes of invasive breast cancer.

Kwon, M J; Park, S; Choi, J Y; Oh, E; Kim, Y J; Park, Y-H; Cho, E Y; Kwon, M J; Nam, S J; Im, Y-H; Shin, Y K; Choi, Y-L

Kwon, M J; Park, S; Choi, J Y; Oh, E; Kim, Y J; Park, Y-H; Cho, E Y; Kwon, M J; Nam, S J; Im, Y-H; Shin, Y K; Choi, Y-L.

Affiliation

Kwon MJ; Advanced Institutes of Convergence Technology, Suwon, Gyeonggi-do, Korea.

Br J Cancer ; 106(5): 923-30, 2012 Feb 28.

Article in En | MEDLINE | ID: mdl-22294188

Subject(s)

Breast Neoplasms/metabolism; Breast Neoplasms/pathology; Neoplasm Invasiveness; Tetraspanin 24/biosynthesis; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor/biosynthesis; Disease-Free Survival; Female; Humans; Immunohistochemistry; Middle Aged; Molecular Targeted Therapy; Prognosis; Receptor, ErbB-2/metabolism; Receptors, Estrogen/biosynthesis; Receptors, Progesterone/metabolism; Tissue Array Analysis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Tetraspanin 24 / Neoplasm Invasiveness Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2012 Document type: Article

Fulltext

XML

PubMed Links

Search on Google